Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers
Dimerization of the thrombopoietin receptor (TpoR) is necessary for receptor activation and downstream signaling through activated Janus kinase 2. We have shown previously that different orientations of the transmembrane (TM) helices within a receptor dimer can lead to different signaling outputs. H...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
eLife Sciences Publications
2023
|
| _version_ | 1826311013596659712 |
|---|---|
| author | Defour, J-P Leroy, E Dass, S Balligand, T Levy, G Brett, IC Papadopoulos, N Mouton, C Genet, L Pecquet, C Staerk, J Smith, SO Constantinescu, SN |
| author_facet | Defour, J-P Leroy, E Dass, S Balligand, T Levy, G Brett, IC Papadopoulos, N Mouton, C Genet, L Pecquet, C Staerk, J Smith, SO Constantinescu, SN |
| author_sort | Defour, J-P |
| collection | OXFORD |
| description | Dimerization of the thrombopoietin receptor (TpoR) is necessary for receptor activation and downstream signaling through activated Janus kinase 2. We have shown previously that different orientations of the transmembrane (TM) helices within a receptor dimer can lead to different signaling outputs. Here we addressed the structural basis of activation for receptor mutations S505N and W515K that induce myeloproliferative neoplasms. We show using <i>in vivo</i> bone marrow reconstitution experiments that ligand-independent activation of TpoR by TM asparagine (Asn) substitutions is proportional to the proximity of the Asn mutation to the intracellular membrane surface. Solid-state NMR experiments on TM peptides indicate a progressive loss of helical structure in the juxtamembrane (JM) R/KWQFP motif with proximity of Asn substitutions to the cytosolic boundary. Mutational studies in the TpoR cytosolic JM region show that loss of the helical structure in the JM motif by itself can induce activation, but only when localized to a maximum of six amino acids downstream of W515, the helicity of the remaining region until Box 1 being required for receptor function. The constitutive activation of TpoR mutants S505N and W515K can be inhibited by rotation of TM helices within the TpoR dimer, which also restores helicity around W515. Together, these data allow us to develop a general model for activation of TpoR and explain the critical role of the JM W515 residue in the regulation of the activity of the receptor. |
| first_indexed | 2024-03-07T08:00:30Z |
| format | Journal article |
| id | oxford-uuid:70e7c7c3-7cf4-43c2-8adf-b7aad5aeb345 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T08:00:30Z |
| publishDate | 2023 |
| publisher | eLife Sciences Publications |
| record_format | dspace |
| spelling | oxford-uuid:70e7c7c3-7cf4-43c2-8adf-b7aad5aeb3452023-09-28T12:15:47ZConstitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimersJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:70e7c7c3-7cf4-43c2-8adf-b7aad5aeb345EnglishSymplectic ElementseLife Sciences Publications2023Defour, J-PLeroy, EDass, SBalligand, TLevy, GBrett, ICPapadopoulos, NMouton, CGenet, LPecquet, CStaerk, JSmith, SOConstantinescu, SNDimerization of the thrombopoietin receptor (TpoR) is necessary for receptor activation and downstream signaling through activated Janus kinase 2. We have shown previously that different orientations of the transmembrane (TM) helices within a receptor dimer can lead to different signaling outputs. Here we addressed the structural basis of activation for receptor mutations S505N and W515K that induce myeloproliferative neoplasms. We show using <i>in vivo</i> bone marrow reconstitution experiments that ligand-independent activation of TpoR by TM asparagine (Asn) substitutions is proportional to the proximity of the Asn mutation to the intracellular membrane surface. Solid-state NMR experiments on TM peptides indicate a progressive loss of helical structure in the juxtamembrane (JM) R/KWQFP motif with proximity of Asn substitutions to the cytosolic boundary. Mutational studies in the TpoR cytosolic JM region show that loss of the helical structure in the JM motif by itself can induce activation, but only when localized to a maximum of six amino acids downstream of W515, the helicity of the remaining region until Box 1 being required for receptor function. The constitutive activation of TpoR mutants S505N and W515K can be inhibited by rotation of TM helices within the TpoR dimer, which also restores helicity around W515. Together, these data allow us to develop a general model for activation of TpoR and explain the critical role of the JM W515 residue in the regulation of the activity of the receptor. |
| spellingShingle | Defour, J-P Leroy, E Dass, S Balligand, T Levy, G Brett, IC Papadopoulos, N Mouton, C Genet, L Pecquet, C Staerk, J Smith, SO Constantinescu, SN Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| title | Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| title_full | Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| title_fullStr | Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| title_full_unstemmed | Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| title_short | Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| title_sort | constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers |
| work_keys_str_mv | AT defourjp constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT leroye constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT dasss constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT balligandt constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT levyg constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT brettic constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT papadopoulosn constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT moutonc constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT genetl constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT pecquetc constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT staerkj constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT smithso constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers AT constantinescusn constitutiveactivationandoncogenicityaremediatedbylossofhelicalstructureatthecytosolicboundaryofthrombopoietinreceptormutantdimers |